Xcout Intel
Atrandi Biosciences
Atrandi Biosciences is a life sciences company pioneering next-generation single-cell analysis technology and semi-permeable capsule solutions.
Subscribe to see Atrandi Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Atrandi Biosciences at a glance
Atrandi Biosciences is a biotechnology company headquartered in Lithuania. Its most recent funding round, Series A, raised $25M in February 2025. Xcout tracks 8 named people at Atrandi Biosciences, including Dalius Jankevičius (Chief Finance Officer).
Atrandi Biosciences leadership
- Dalius JankevičiusChief Finance Officer
- Sam RoppChief Commercial Officer
- Juozas NainysCo-Founder & Chief Executive Officer
- Karolis LeonavičiusCo-Founder & Chief Technology Officer
- Rapolas ŽilionisCo-Founder & Chief Scientific Officer
- Linas Mazutisfounder
2 more named people on record for Atrandi Biosciences, with roles, board committees and tenure — see the full roster →
Atrandi Biosciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $25M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Atrandi Biosciences competitors
A few of Atrandi Biosciences's closest competitors — see the full list of competitors and alternatives →
Axbio is a semiconductor-biotechnology company headquartered in Santa Clara, California. The firm combines semiconductor technology with life sciences to develop products aimed at improving health and safeguarding well-being.
Intus Biosciences develops proprietary microbiome analysis technology that combines patented science, long-read sequencing, and AI to deliver strain-level resolution of microbial data. The company serves healthcare providers, researchers, and consumers through clinical-grade profiling products like GutID and research partnerships aimed at drug development and biomarker discovery.
Nimble Science is a digital health and precision medicine company headquartered in Calgary, Canada, that delivers small intestine sampling technology and multi-omic data.
Aagamiseq Technologies Private Limited is a deep-tech startup founded in 2024 and based in Bengaluru, India. The company develops next-generation automated biotechnology systems and diagnostic platforms utilizing solid-state micropore and nanopore technologies for single-cell and single-molecule applications.
Deep Cell Industries Inc. provides an AI-integrated platform called REM-I that combines label-free imaging, deep learning, and cell enrichment for single-cell morpholomic analysis. The company serves researchers and organizations in oncology, drug discovery, cell and gene therapy, and related life science fields by enabling high-resolution profiling and sorting of viable cells.
Cellanome is a biotechnology company that reimagines how scientists study living cells by enabling researchers to capture the intricacies and biology of cells in motion rather than through static snapshots.
Get Atrandi Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Atrandi Biosciences in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access